{{Cite journal| doi = 10.1016/j.thromres.2023.08.009| issn = 1879-2472 (Electronic) 0049-3848 (Linking)| volume = 230| pages = 27–32| last1 = Barco| first1 = S.| last2 = Virdone| first2 = S.| last3 = Gotschi| first3 = A.| last4 = Ageno| first4 = W.| last5 = Arcelus| first5 = J. I.| last6 = Bingisser| first6 = R.| last7 = Colucci| first7 = G.| last8 = Cools| first8 = F.| last9 = Duerschmied| first9 = D.| last10 = Gibbs| first10 = H.| last11 = Fumagalli| first11 = R. M.| last12 = Gerber| first12 = B.| last13 = Haas| first13 = S.| last14 = Himmelreich| first14 = J. C. L.| last15 = Hobbs| first15 = R.| last16 = Hobohm| first16 = L.| last17 = Jacobson| first17 = B.| last18 = Kayani| first18 = G.| last19 = Lopes| first19 = R. D.| last20 = MacCallum| first20 = P.| last21 = Micieli| first21 = E.| last22 = Righini| first22 = M.| last23 = Robert-Ebadi| first23 = H.| last24 = Rocha| first24 = A. T.| last25 = Rosemann| first25 = T.| last26 = Sawhney| first26 = J.| last27 = Schellong| first27 = S.| last28 = Sebastian| first28 = T.| last29 = Spirk| first29 = D.| last30 = Stortecky| first30 = S.| last31 = Turpie| first31 = A. G. G.| last32 = Voci| first32 = D.| last33 = Kucher| first33 = N.| last34 = Pieper| first34 = K.| last35 = Held| first35 = U.| last36 = Kakkar| first36 = A. K.| last37 = Ovid| last38 = Investigators| first38 = Ethic| title = Enoxaparin for symptomatic COVID-19 managed in the ambulatory setting: An individual patient level analysis of the OVID and ETHIC trials| journal = Thromb Res| date = 2023-08-25| pmid = 37625200}}